• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Clinical evaluation between Systolic and Diastolic Heart failure

    Panchanan Sahoo, Ritesh Acharya

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 636-641

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Objectives: Diastolic heart failure (DHF) and Systolic heart failure (SHF) are two
clinical subtypes of the Chronic Heart Failure (CHF) syndrome that is most frequently
seen in clinical practise. SHF and DHF are the two most common clinical subgroups of
Chronic Heart Failure syndrome. To assess the frequencies of CHF and the systolic
dysfunction (SD) and diastolic dysfunction (DD) in the community. To also ascertain
whether DD helps in predicting all-cause mortality.
Study design and sample: This cross-sectional study of 242 participants who have been
selected randomly will be conducted in the state of Bhubaneshwar, India. The inclusive
criteria of the sample are that the age groups must be 45 years or older. This study took
place between June 2020 to July 2021.
Results: Validated CHF was found in 2.2 percent of the participants, with 44 percent of
participants with an EF greater than 50%. 20.8 percent of participants had mild
diastolic disfunction, 6.6 percent had moderate DD, and 0.7 percent had severe DD.
There was a 6.0 percent occurrence of any SD, with 2.0 percent having severe or
moderate SD. People with SD or DD had considerably higher rates of CHF than those
participants with normal cardiac function. Even among individuals with severe or
moderate DD or SD, however, only around half had heard of CHF. Mild DD, severe or
moderate DD, and severe or moderate SD were predictive of mortality across
multivariate analysis, adjusted for sex, EF and age.
Conclusion: SD is present among people who do not have recognised CHF. DD is
common and is not accompanied by CHF. It is associated with an elevation in mortality.
Keywords:
  • PDF (246 K)
  • XML
(2022). Clinical evaluation between Systolic and Diastolic Heart failure. European Journal of Molecular & Clinical Medicine, 9(3), 636-641.
Panchanan Sahoo, Ritesh Acharya. "Clinical evaluation between Systolic and Diastolic Heart failure". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 636-641.
(2022). 'Clinical evaluation between Systolic and Diastolic Heart failure', European Journal of Molecular & Clinical Medicine, 9(3), pp. 636-641.
Clinical evaluation between Systolic and Diastolic Heart failure. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 636-641.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 64
  • PDF Download: 132
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus